Recombinant Pongo abelii cytochrome c oxidase assembly protein COX11, mitochondrial (COX11) is a biotechnologically engineered protein critical for studying mitochondrial respiratory chain assembly. Produced in E. coli with an N-terminal His tag, this 249-amino-acid protein (29–277 aa, UniProt ID: Q5R7U6) facilitates copper ion delivery to cytochrome c oxidase (Complex IV) during its maturation . Its recombinant form enables biochemical and structural investigations into mitochondrial energy production mechanisms and associated pathologies.
COX11 operates in the final stages of Complex IV (cytochrome c oxidase) biogenesis:
Copper Delivery: Dimeric COX11 transfers Cu(I) ions from a 2Cu(I)-4S cluster to the Cu<sub>B</sub> site of the catalytic subunit MT-CO1 .
Assembly Intermediate Stabilization: Interacts with SURF1 (Shy1 in yeast) and structural subunits COX4/COX5A during heme A insertion .
Redox Regulation: Requires reduced cysteine residues (maintained by COX19) for copper transfer efficiency .
COX11 dimer "floats" on the mitochondrial inner membrane, anchored by transmembrane helices.
Flexible linkers position the 2Cu(I)-4S cluster near MT-CO1’s histidine ligands.
Thiolate coordination transfers Cu(I) to MT-CO1, forming the Cu<sub>B</sub> center .
Yeast Complementation: S. cerevisiae COX11 homologs cannot be replaced by Arabidopsis COX11, highlighting species-specific functional divergence .
Plant Models: Arabidopsis COX11 knockdowns exhibit 50% reduced COX activity, root growth defects, and impaired pollen germination .
| Product Code | Species | Tag | Source | Vendor |
|---|---|---|---|---|
| RFL25127PF | Pongo abelii | His | E. coli | Creative BioMart |
| CSB-CF728956PYX | Pongo abelii | Variable | E. coli | Cusabio |
| COX11-1993HF | Human | GST | Mammalian | Creative BioMart |
Anti-COX11 Antibodies: Available for human, mouse, and rat (e.g., CSB-PA005825GA01HU) .
ELISA Kits: Detect recombinant COX11 at 1.0–10 ng/mL sensitivity .
Reconstitution: Requires sterile deionized water + 5–50% glycerol for long-term stability .
Activity Assays: Monitor COX activity via polarographic oxygen measurements or BN-PAGE of assembly intermediates .
Mutagenesis Studies: Cys-111Ala mutations abolish copper transfer, confirming redox-sensitive functionality .
STRING: 9601.ENSPPYP00000009281
UniGene: Pab.5298
COX11 functions as a copper chaperone that participates in the assembly of complex IV (cytochrome c oxidase) of the mitochondrial respiratory chain. It plays a critical role in facilitating the incorporation of copper ions into the catalytic center of complex IV, which is essential for electron transport and cellular respiration. This copper chaperone activity is highly conserved across species, from unicellular organisms to primates, indicating its fundamental importance in cellular bioenergetics. Defects in COX11 function can lead to impaired complex IV assembly and decreased cellular ATP production .
The COX11 protein has a distinctive three-dimensional structure characterized by:
A β-strand fold organized into a homodimeric structure
An antiparallel arrangement forming a binuclear copper cluster at the dimer interface
N-terminal transmembrane helices that anchor the dimer to the inner mitochondrial membrane
Orientation of the two copper ions toward the membrane to facilitate copper transfer
This structural arrangement positions the protein optimally for its function in copper delivery to the nascent cytochrome c oxidase complex. The copper-binding site is formed at the interface between two monomers, creating a binuclear copper cluster that is essential for its chaperone activity .
While the search results don't provide specific sequence comparisons between Pongo abelii and human COX11, evolutionary conservation analyses suggest high similarity across primates. Critical functional domains, particularly the copper-binding motifs and transmembrane regions, show strong conservation. The copper-binding domain typically contains conserved cysteine residues that are essential for metal coordination. For conducting comparative studies, researchers should consider that while the core functional domains are highly conserved, species-specific variations may occur in less functionally constrained regions, potentially affecting protein stability or interaction profiles .
For recombinant expression of Pongo abelii COX11, several expression systems can be employed based on research requirements:
Bacterial Expression (E. coli):
Advantages: High yield, cost-effective, rapid growth
Considerations: May lack proper post-translational modifications; requires optimization of codon usage for primate sequences
Recommended for: Structural studies, antibody production, protein-protein interaction studies
Yeast Expression (S. cerevisiae):
Advantages: Eukaryotic post-translational modifications, suitable for functional studies
Applications: Particularly valuable for complementation studies as demonstrated in COX11 mutation research
Methodology: Transformation with shuttle vectors containing the Pongo abelii COX11 gene under control of an inducible promoter
Mammalian Cell Lines:
Advantages: Most physiologically relevant system, proper folding and modifications
Applications: Functional studies, localization experiments, interaction analyses
Methodology: Transient or stable transfection with expression vectors containing CMV or similar promoters
The choice of expression system should be guided by the specific research questions. For studies focusing on basic protein-protein interactions, bacterial systems may suffice, while functional studies would benefit from yeast or mammalian expression systems .
Multiple complementary approaches can be employed to characterize COX11 protein-protein interactions:
Co-immunoprecipitation (Co-IP):
Methodology: Use of specific antibodies against COX11 or potential interacting partners to pull down protein complexes
Analysis: Western blotting to detect co-precipitated proteins
Advantages: Captures native interactions in cellular context
Yeast Two-Hybrid (Y2H):
Methodology: Fusion of COX11 to DNA-binding domain and target proteins to activation domain
Analysis: Reporter gene activation indicates interaction
Applications: Screen for novel interaction partners or validate specific interactions
Bimolecular Fluorescence Complementation (BiFC):
Methodology: Split fluorescent protein fragments fused to COX11 and potential partners
Analysis: Fluorescence microscopy to detect reconstituted fluorescence
Advantages: Visualizes interactions in living cells with subcellular resolution
Evidence from research on human COX11 suggests interactions with other components of the cytochrome c oxidase assembly pathway. For example, interaction studies have shown that COX11 can interact with cytochrome c oxidase subunits, particularly with the COX1 subunit during copper insertion. In particular, Os_CoxVIIa, a subunit of cytochrome c oxidase, has been observed to interact with Cox11 in some experimental systems .
Assessment of COX11 chaperone activity requires specialized biochemical assays focusing on copper handling and transfer capabilities:
Copper-Binding Assay:
Methodology: Incubation of purified recombinant COX11 with copper ions (Cu^1+) followed by size exclusion chromatography
Analysis: Atomic absorption spectroscopy or ICP-MS to quantify bound copper
Controls: Mutated versions of COX11 with alterations in copper-binding sites
Copper Transfer Assay:
Methodology: Pre-loading COX11 with copper and measuring transfer to acceptor proteins/peptides
Analysis: Fluorescent probes sensitive to copper binding or displacement
Applications: Determine copper transfer kinetics and specificity
Complex IV Assembly Assay:
Methodology: Complementation of COX11-deficient cell lines with wild-type or mutant COX11
Analysis: BN-PAGE (Blue Native Polyacrylamide Gel Electrophoresis) to assess complex IV assembly
Quantification: Activity staining for cytochrome c oxidase activity
Research has shown that mutations affecting conserved cysteine residues can significantly impact copper binding and transfer functions. For example, studies of Cox11 homologs have demonstrated that cysteine residues at positions equivalent to human positions 25 and 126 are essential for function .
Several pathogenic variants in COX11 have been identified and characterized:
| Mutation | Protein Change | Structural/Functional Impact | Clinical Presentation |
|---|---|---|---|
| p.A244P | Alanine to Proline at position 244 | Altered protein stability (ΔΔG monomer: 0.93 ± 0.04 kcal/mol) | Infantile-onset mitochondrial encephalopathy |
| p.P247T | Proline to Threonine at position 247 | Reduced stability (ΔΔG monomer: 1.841 ± 0.002 kcal/mol) | Leigh-like features |
| p.T256Nfs*8 | Frameshift leading to premature termination | Severe destabilization (ΔΔG monomer: 12.99 ± 2.27 kcal/mol) | Compound heterozygous with P247T causing Leigh-like disease |
These mutations predominantly affect protein stability rather than directly impacting the copper-binding site. The frameshift mutation (p.T256Nfs*8) causes the most severe structural disruption, replacing the C-terminal 21 amino acids with 7 alternative amino acids. Structure-based analysis reveals that these mutations alter protein flexibility and dynamics, particularly in regions where the mutated residues are located .
Mutations in COX11 lead to cascading effects on mitochondrial function:
Impaired Complex IV Assembly: Primary consequence of COX11 dysfunction, resulting in reduced cytochrome c oxidase levels
Decreased Cellular ATP Production: Reduction in oxidative phosphorylation capacity
Metabolic Reprogramming: Shift toward glycolytic metabolism to compensate for impaired respiration
Increased Sensitivity to Oxidative Stress: Particularly evident in cells with truncated COX11, suggesting a potential role in redox homeostasis
Intriguingly, ATP levels in cells with COX11 mutations can be partially rescued by coenzyme Q10 (CoQ10) supplementation, despite COX11 having no known direct role in CoQ10 biosynthesis. This suggests complex metabolic interactions between different components of the respiratory chain and potential compensatory mechanisms that could be therapeutically exploited .
Studies using COX11-deficient models have demonstrated altered growth patterns and substantial metabolic disruptions, highlighting the critical role of properly functioning COX11 in maintaining energy homeostasis .
Based on current research, several therapeutic strategies show potential for addressing COX11-associated disorders:
CoQ10 Supplementation:
Mechanism: While not directly addressing the primary defect, CoQ10 has been shown to improve ATP production in COX11-deficient cells
Evidence: Functional studies showed that mutant COX11 fibroblasts had decreased ATP levels which could be rescued by CoQ10 supplementation
Application: May serve as a metabolic bypass strategy to enhance electron transport
Copper Supplementation:
Rationale: As COX11 functions as a copper chaperone, copper bioavailability might influence disease severity
Considerations: Requires careful dosing due to potential toxicity; may be more effective in certain variants
Gene Therapy Approaches:
Strategy: Delivery of functional COX11 using viral vectors
Target tissues: Primarily affected tissues such as brain and muscle
Challenges: Delivery across blood-brain barrier, achieving appropriate expression levels
Small Molecule Chaperones:
Approach: Compounds that stabilize mutant COX11 protein structure
Mechanism: Prevention of protein misfolding and degradation
Candidates: Structure-based drug design targeting specific variants
The discovery that CoQ10 can rescue ATP production in COX11-deficient cells represents a particularly interesting finding that merits further investigation for clinical applications .
COX11 provides an excellent model system for investigating mitochondrial copper trafficking mechanisms:
Copper Sensing Applications:
Approach: Engineering COX11-based fluorescent biosensors for mitochondrial copper
Methodology: Fusion of fluorescent protein domains to COX11 to create FRET-based sensors
Applications: Real-time monitoring of copper dynamics in living cells
Cross-Species Comparative Studies:
Approach: Analysis of COX11 structure and function across evolutionary distinct organisms from yeast to primates
Benefits: Identification of conserved mechanisms and species-specific adaptations
Application: Using lower organisms like yeast as tractable models for human disease
Mitochondrial Copper Homeostasis Network:
Research focus: Mapping interactions between COX11 and other copper chaperones/transporters
Methodology: Proteomics approaches to identify the complete interactome
Significance: Understanding the integrated network controlling mitochondrial copper utilization
The structural analysis of COX11 reveals a binuclear copper cluster at the dimer interface, with N-terminal transmembrane helices anchoring the dimer to the inner mitochondrial membrane. This specific arrangement facilitates copper transfer, making COX11 an ideal model for studying copper trafficking mechanisms in mitochondria .
Emerging evidence suggests COX11 involvement in cellular responses to oxidative stress:
Peroxide Sensitivity:
Observation: Premature truncation of COX11 leads to increased sensitivity to hydrogen peroxide
Mechanism: Potentially related to impaired respiratory chain function leading to increased ROS production
Experimental evidence: Yeast models with truncated COX11 (Y250*) show significantly increased sensitivity to oxidative challenges
Redox Signaling:
Hypothesis: COX11 may function in redox signaling pathways beyond its role in complex IV assembly
Supporting evidence: Conserved cysteine residues (positions 25 and 126) that are sensitive to oxidation state
Potential mechanism: Conformational changes in response to redox environment affecting protein interactions
Antioxidant Defense Connection:
Observation: COX11 deficiency alters cellular redox status
Research direction: Investigation of links between COX11 function and antioxidant defense systems
Methodology: Measuring oxidative stress markers and antioxidant enzyme activities in COX11-deficient models
The dual roles observed in some COX11 homologs, such as immunosuppression and cell death induction during pathogenesis, may provide insights into how this protein family responds to and influences cellular stress responses .
Comparative studies between human and Pongo abelii COX11 can provide valuable evolutionary insights:
Evolutionary Rate Analysis:
Approach: Calculation of dN/dS ratios to identify selective pressures on COX11 in different primate lineages
Hypothesis: Conservation of functional domains versus potential adaptive evolution in lineage-specific regions
Methodology: Phylogenetic analysis incorporating multiple primate species
Structure-Function Relationships:
Focus: Identifying species-specific variations that might affect protein stability or interaction profiles
Approach: Recombinant expression of both human and Pongo abelii COX11 for comparative functional assays
Applications: Testing interchangeability in complementation experiments
Mitochondrial-Nuclear Co-evolution:
Research question: How has COX11 (nuclear-encoded) co-evolved with mitochondrial-encoded complex IV subunits?
Significance: Understanding constraints in mitonuclear protein interactions across primates
Methodology: Correlation analysis between COX11 changes and mitochondrial genome evolution
While the search results don't provide direct comparative data between human and Pongo abelii COX11, such studies would contribute significantly to our understanding of primate mitochondrial evolution and potentially identify species-specific adaptations in energy metabolism .
Accurate quantification of COX11 expression requires appropriate methodology selection based on research objectives:
RT-qPCR (mRNA Quantification):
Protocol: RNA extraction, reverse transcription, and quantitative PCR with COX11-specific primers
Reference genes: Recommended stable references include GAPDH, ACTB, and mitochondrial housekeeping genes
Applications: Tissue expression profiling, response to experimental conditions
Considerations: Measures transcript levels, not protein abundance
Western Blotting (Protein Quantification):
Protocol: Subcellular fractionation to isolate mitochondria prior to SDS-PAGE and immunoblotting
Loading controls: Mitochondrial markers such as VDAC or complex II subunits
Quantification: Densitometric analysis with normalization to loading controls
Applications: Protein abundance studies, mutation impact assessment
Immunofluorescence Microscopy (Localization and Semi-quantification):
Protocol: Fixation, permeabilization, and immunostaining with COX11-specific antibodies
Colocalization: With mitochondrial markers such as MitoTracker or TOM20
Analysis: Image quantification using fluorescence intensity measurements
Applications: Subcellular localization, potential mislocalization of mutant forms
For comprehensive analysis, combining multiple methodologies is recommended. For instance, in studies of COX11 mutations, researchers employed both protein quantification and localization studies to characterize the impact of specific variants on protein expression and distribution .
Interpretation of complex IV activity in relation to COX11 manipulation requires consideration of several factors:
Activity Assay Selection:
Spectrophotometric assays: Measure cytochrome c oxidation rate
Polarographic methods: Oxygen consumption measurement
Histochemical staining: Visual assessment of complex IV activity in tissues or cells
Data Interpretation Framework:
| Parameter | Normal COX11 | Partial COX11 Deficiency | Complete COX11 Loss |
|---|---|---|---|
| Complex IV Activity | 100% | 30-70% of control | <10% of control |
| Assembly Status | Fully assembled complex | Partially assembled intermediates | Absence of fully assembled complex |
| Copper Content | Normal copper incorporation | Reduced copper in complex IV | Minimal copper incorporation |
Confounding Factors:
Compensatory mechanisms: Upregulation of alternative respiratory pathways
Tissue-specific effects: Differential sensitivity across cell types
Threshold effects: Nonlinear relationship between COX11 levels and complex IV activity
Research has shown that complete depletion of complex IV activity, as observed in the cox11
mutant in P. patens, leads to altered growth patterns and significant metabolic disruptions. This highlights the critical threshold of complex IV activity required for normal cellular function .
Analysis of COX11 mutation effects on protein stability requires robust statistical methods:
Thermodynamic Stability Analysis:
Approach: Calculation of ΔΔG values (difference in Gibbs free energy between wild-type and mutant protein)
Tool recommendation: FoldX or similar computational tools
Statistical handling: Multiple independent runs (e.g., five runs) to establish confidence intervals
Significance threshold: Changes within predicted error range of 0.5 kcal/mol considered insignificant
Comparative Mutation Analysis:
Method: ANOVA with post-hoc tests for comparing multiple mutations
Application: Ranking mutations by severity of impact on protein stability
Visualization: Box plots or violin plots to display distribution of stability predictions
Structure-Function Correlation:
Approach: Regression analysis between stability metrics and functional outcomes
Variables: ΔΔG values versus biochemical or cellular phenotypes
Application: Establishing predictive models for mutation pathogenicity
In a study of COX11 mutations, researchers employed five independent runs for each mutation and calculated the thermodynamic stability changes. The analysis revealed a hierarchy of destabilizing effects: T256Nfs*8 (ΔΔG monomer: 12.99 ± 2.27 kcal/mol) > P247T (1.841 ± 0.002 kcal/mol) > A244P (0.93 ± 0.04 kcal/mol). This quantitative approach allows for precise assessment of mutation impacts on protein stability .